U
U.S. Dermatology Partners | Medical Dermatology Specialists Phoenix
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ruxolitinib
Vitamin D
Prednisone
Povorcitinib
Parent organization
This site is a part of U.S. Dermatology Partners
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
Enrolling
Prurigo Nodularis
Drug: Placebo
Drug: Povorcitinib
The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).
Active, not recruiting
Prurigo
Drug: Ruxolitinib Cream
Drug: Vehicle Cream
The purpose of this study is to find out whether a medicine called spesolimab helps people with pyoderma gangrenosum (PG). The main aim is to see whe...
Begins enrollment this month
Pyoderma Gangrenosum
Drug: Prednisolone
Drug: Prednisone
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems